Association between circulating level of CD40 ligand and angiographic morphologic features indicating high-burden thrombus formation in patients with acute myocardial infarction undergoing primary coronary intervention

Circulation Journal

Volumn 71, Issue 12, 2007, Pages 1857-1861

  Youssef, Ali A ^a   Chang, Li Teh ^b   Sheu, Jiunn Jye ^c   Lee, Fan Yen ^c   Chua, Sarah ^c   Yeh, Kuo Ho ^c   Yang, Cheng Hsu ^c   Wu, Chiung Jen ^c   Yip, Hon Kan ^c,d  

^a Suez Canal University Hospital   (Egypt)

^b MEIHO UNIVERSITY   (Taiwan)

^c CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^d CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Acute myocardial infarction; Angiography; High burden thrombus formation; Morphology; Soluble CD40 ligand

Indexed keywords

ACETYLSALICYLIC ACID; C REACTIVE PROTEIN; CD40 LIGAND; CLOPIDOGREL; TIROFIBAN;

ACUTE HEART INFARCTION; ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; FEMALE; HUMAN; LEUKOCYTE COUNT; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PREMEDICATION; ST SEGMENT ELEVATION; SYSTEMIC CIRCULATION; THROMBOGENESIS;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTIGENS, CD40; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; LEUKOCYTE COUNT; LIGANDS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; PLATELET ACTIVATION; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; THROMBOSIS;

EID: 37149053581     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.71.1857     Document Type: Article

References (25)

1. Theroux P, Fusters V. Acute coronary syndromes. Unstable angina and non-Q wave myocardial infarction: Clinical cardiology: New frontiers. Circulation 1998; 97: 1195-1206.
2. Gawaz M. Role of platelets in coronary thrombosis and reperfusion ischemic myocardium. Cardiovasc Res 2004; 61: 498-511.
3. Yip HK, Chen SS, Liu JS, Chang HW, Kao YF, Lan MY, et al. Serial changes in platelet activation in patients after ischemic stroke: Role of pharmacodynamic modulation. Stroke 2004; 35: 1683-1687.
4. Kabbani SS, Watkins MW, Ashikaga T, Terrien ET, Holoch PA, Sobel BE, et al. Platelet reactivity characterized prospectively a determinant of outcome 90 days after percutaneous coronary intervention. Circulation 2001; 104: 181-186.
5. Yip HK, Liou CW, Chang HW, Lan MY, Liu JS, Chen MC. Link between platelet activity and outcomes after ischemic stroke. Cerebrovasc Dis 2005; 20: 120-128.
6. Yip HK, Chang LT, Sun CK, Chen MC, Yang CH, Hung WC, et al. Platelet activity is a biomarker of cardiac necrosis and predictive of untoward clinical outcomes in patients with acute myocardial infarction undergoing primary coronary stenting. Circ J 2006; 70: 31-36.
7. Yip HK, Lai SL, Lan MY, Chang WN, Liu JS, Kao YF, et al. Time course of platelet activation and von Willebrand factor in patients with nonvalvular atrial fibrillation after ischemic stroke: Evaluation of prognostic determinants. Circ J 2007; 71: 321-326.
8. Antoniades C, Tousoulis D, Vasiliadou C, Stefanadi E, Marinou K, Stefanadis C. Genetic polymorphisms of platelet glycoprotein Ia and the risk for premature myocardial infarction: Effects on the release of cCD40L during the acute phase of premature myocardial infarction. J Am Coll Cardiol 2006; 47: 1959-1966.
9. Cipollone F, Ferri C, Desideri G, Paloscia L, Materazzo G, Mascellanti M, et al. Preprocedural level of soluble CD40L is predictive of enhanced inflammatory response and restenosis after coronary angioplasty. Circulation 2003; 108: 2776-2782.
10. Henn V, Slupsky JR, Grafe M, Anagnostopoulos L, Forster R, Muller-Berghaus G, et al. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 1998; 391: 591-594.
11. Aukrust P, Muller F, Ueland T, Berget T, Aaser E, Brunsvig A, et al. Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina: Possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes. Circulation 1999; 100: 614-620.
12. Andre P, Nannizzi-Alaimo L, Prasad SK, Phillips DR. Platelet derived CD40L: The switch-hitting player of cardiovascular disease. Circulation 2002; 106: 689-899.
13. Freedman JE. CD40 ligand-assessing risk instead of damage? N Engl J Med 2003; 348: 1163-1165.
14. Yip HK, Wu CJ, Chang HW, Chen MC, Hang CL, Fang CY, et al. Comparison of impact of primary percutaneous transluminal coronary angioplasty and primary stenting on short-term mortality in patients with cardiogenic shock and evaluation of prognostic determinants. Am J Cardiol 2001; 87: 1184-1188.
15. Yip HK, Chen MC, Chang HW, Hang CL, Hsieh YK, Fang CY, et al. Angiographic morphologic features of infarct-related arteries and timely reperfusion in acute myocardial infarction: Predictors of slow-flow and no-reflow. Chest 2002; 122: 1322-1332.
16. Tanaka A, Kawarabayashi T, Nishibori Y, Sano T, Nishida Y, Fukuda D, et al. No-reflow phenomenon and lesion morphology in patients with acute myocardial infarction. Circulation 2002; 105: 2148-2152.
17. Yip HK, Wu CJ, Chang HW, Hsieh YK, Fang CY, Chen SM, et al. Impact of tirofiban on angiographic morphologic features of high-burden thrombus formation during direct percutaneous coronary intervention and short-term outcomes. Chest 2003; 24: 962-968.
18. Yip HK, Wu CJ, Chang HW, Fang CY, Yang CH, Chen SM, et al. Effect of the PercuSurge GuardWire™ device on the integrity of microvasculature and clinical outcomes during primary transradial coronary intervention. Am J Cardiol 2003; 92: 1331-1335.
19. Hoshiba Y, Hatakeyama K, Tanabe T, Asada Y, Goto S. Co-localization of von Willebrand factor with platelet thrombi, tissue factor and platelets with fibrin, and consistent presence of inflammatory cells in coronary thrombi obtained by an aspiration device from patients with acute myocardial infarction. J Thromb Haemost 2006; 4: 114-120.
20. Schonbeck U, Libby P. CD40L signaling and plaque instability. Circ Res 2001; 89: 1092-1103.
21. Montalescot G, Barragan P, Wittenberg O, Ecollan P, Elhadad S, Villain P, et al. Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction. N Engl J Med 2001; 344: 1895-1903.
22. Barron HV, Cannon CP, Murphy SA, Braunwald E, Gibson M. Association between white blood cell count, epicardial blood flow, myocardial perfusion, and clinical outcomes in the setting of acute myocardial infarction: A thrombolysis in myocardial infarction 10 substudy. Circulation 2000; 102: 2329-2334.
23. Barron HV, Harr SD, Radfort MJ, Wang Y, Krumholz HM. The association between white blood cell count and acute myocardial infarction mortality in patients ≥65 years of age: Undings from the cooperative cardiovascular project. J Am Coll Cardiol 2001; 38: 1654-1661.
24. Palabrica T, Lobb R, Furie BC, Aronovitz M, Benjamin C, Hsu YM, et al. Leukocyte accumulation promoting fibrin deposition is mediated in vivo by p-selectin on adherent platelets. Nature 1992; 359: 848-851.
25. Cipollone F, Ferri C, Desideri G, Paloscia L, Materazzo G, Mascellanli M, et al. Preprocedural level of soluble CD40L is predictive of enhanced inflammatory response and restenosis after coronary angioplasty. Circulation 2003; 108: 2776-2782.